Literature DB >> 17689954

Medical exposure to ionising radiation and the risk of brain tumours: Interphone study group, Germany.

Maria Blettner1, Brigitte Schlehofer, Florence Samkange-Zeeb, Gabriele Berg, Klaus Schlaefer, Joachim Schüz.   

Abstract

BACKGROUND: The role of exposure to low doses of ionising radiation in the aetiology of brain tumours has yet to be clarified. The objective of this study was to investigate the association between medically or occupationally related exposure to ionising radiation and brain tumours.
METHODS: We used self-reported medical and occupational data collected during the German part of a multinational case-control study on mobile phone use and the risk of brain tumours (Interphone study) for the analyses.
RESULTS: For any exposure to medical ionising radiation we found odds ratios (ORs) of 0.63 (95% confidence interval (CI)=0.48-0.83), 1.08 (95% CI=0.80-1.45) and 0.97 (95% CI=0.54-1.75) for glioma, meningioma and acoustic neuroma, respectively. Elevated ORs were found for meningioma (OR 2.32, 95% CI: 0.90-5.96) and acoustic neuroma (OR 6.45, 95% CI: 0.62-67.16) for radiotherapy to the head and neck regions.
CONCLUSION: We did not find any significant increased risk of brain tumours for exposure to medical ionising radiation.

Entities:  

Mesh:

Year:  2007        PMID: 17689954     DOI: 10.1016/j.ejca.2007.06.020

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  9 in total

Review 1.  Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium.

Authors:  Melissa L Bondy; Michael E Scheurer; Beatrice Malmer; Jill S Barnholtz-Sloan; Faith G Davis; Dora Il'yasova; Carol Kruchko; Bridget J McCarthy; Preetha Rajaraman; Judith A Schwartzbaum; Siegal Sadetzki; Brigitte Schlehofer; Tarik Tihan; Joseph L Wiemels; Margaret Wrensch; Patricia A Buffler
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

2.  Cancer mortality among German aircrew: second follow-up.

Authors:  Hajo Zeeb; Gaël P Hammer; Ingo Langner; Thomas Schafft; Sabrina Bennack; Maria Blettner
Journal:  Radiat Environ Biophys       Date:  2009-10-16       Impact factor: 1.925

Review 3.  Radiation risks associated with serial imaging in colorectal cancer patients: should we worry?

Authors:  Jeong Suk Oh; Jonathan B Koea
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

4.  Medical diagnostic radiation exposures and risk of gliomas.

Authors:  Faith Davis; Dora Il'yasova; Kristin Rankin; Bridget McCarthy; Darell D Bigner
Journal:  Radiat Res       Date:  2011-04-05       Impact factor: 2.841

Review 5.  Cancer and non-cancer brain and eye effects of chronic low-dose ionizing radiation exposure.

Authors:  Eugenio Picano; Eliseo Vano; Luciano Domenici; Matteo Bottai; Isabelle Thierry-Chef
Journal:  BMC Cancer       Date:  2012-04-27       Impact factor: 4.430

6.  Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study.

Authors:  Mark S Pearce; Jane A Salotti; Mark P Little; Kieran McHugh; Choonsik Lee; Kwang Pyo Kim; Nicola L Howe; Cecile M Ronckers; Preetha Rajaraman; Alan W Sir Craft; Louise Parker; Amy Berrington de González
Journal:  Lancet       Date:  2012-06-07       Impact factor: 79.321

Review 7.  Study designs may influence results: the problems with questionnaire-based case-control studies on the epidemiology of glioma.

Authors:  Christoffer Johansen; Joachim Schüz; Anne-Marie Serena Andreasen; Susanne Oksbjerg Dalton
Journal:  Br J Cancer       Date:  2017-03-07       Impact factor: 7.640

8.  Association of Exposure to Diagnostic Low-Dose Ionizing Radiation With Risk of Cancer Among Youths in South Korea.

Authors:  Jae-Young Hong; Kyungdo Han; Jin-Hyung Jung; Jung Sun Kim
Journal:  JAMA Netw Open       Date:  2019-09-04

9.  Pooled analysis of case-control studies on acoustic neuroma diagnosed 1997-2003 and 2007-2009 and use of mobile and cordless phones.

Authors:  Lennart Hardell; Michael Carlberg; Fredrik Söderqvist; Kjell Hansson Mild
Journal:  Int J Oncol       Date:  2013-07-22       Impact factor: 5.650

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.